** Shares of Ansell rise as much as 4.7% to A$32.900, hitting their highest level since Jan 25, 2022
** Stock set for strongest trading session since late August
** Medical equipments supplier revises FY25 adj EPS outlook range to 110-127 US cents from 107-127 US cents
** However, co says higher inflation costs of key raw materials and higher freight costs to have greater impact in H2 FY25
** Stock up 24.8% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru)
((shivangi.lahiri@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。